Verstovsek, SrdanAl-Ali, Haifa KathrinMascarenhas, JohnPerkins, AndrewVannucchi, Alessandro MariaMohan, Sanjay R.Scott, Bart L.Woszczyk, DariuszKoschmieder, SteffenGarcía-Delgado, ReginaRejtő, LászlóMcGreivy, Jesse S.Rothbaum, WayneKiladjian, Jean-Jacques2023-09-082023-09-082022Future Oncology. -18 : 37 (2022), p. 4059-4069. -Future Oncology. - 1479-6694. - 1744-83011479-66941744-8301https://hdl.handle.net/2437/358792BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosisfolyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM114500OrvostudományokKlinikai orvostudományokhttps://www.futuremedicine.com/doi/10.2217/fon-2022-0901szerzőhttp://dx.doi.org/10.2217/fon-2022-09012023-09-0800088981100000185148375730